Kanada - angol - Health Canada

novartis pharmaceuticals canada inc - fingolimod (fingolimod hydrochloride) - capsule - 0.5mg - fingolimod (fingolimod hydrochloride) 0.5mg - immunomodulatory agents

Kanada - angol - Health Canada

novartis pharmaceuticals canada inc - fingolimod (fingolimod hydrochloride) - capsule - 0.25mg - fingolimod (fingolimod hydrochloride) 0.25mg - immunomodulatory agents

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

nutrition care pharmaceuticals pty ltd - dibasic sodium phosphate, quantity: 130 mg; glutamine, quantity: 100 mg; quercetin, quantity: 10 mg; ulmus rubra, quantity: 10 mg; guar gum, quantity: 10 mg; pectin, quantity: 10 mg; polaprezinc, quantity: 75 mg (equivalent: zinc, qty 16.935 mg); curcumin, quantity: 3.1888 mg; lactobacillus reuteri, quantity: 10 mg - capsule, hard - excipient ingredients: magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; betadex; dextrin; hypromellose; disodium edetate; potable water; potassium acetate; gellan gum - helps enhance/promote gastrointestinal system mucosa health ; maintain/support healthy mucous linings of the digestive system ; maintain/support gastrointestinal system health ; maintain/support gastrointestinal mucosal membrane health ; aids/assists repair of gastrointestinal/gut wall lining

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

bio concepts pty ltd - palmidrol, quantity: 600 mg; piper nigrum, quantity: 100 mg (equivalent: piper nigrum, qty 5 g) - capsule, hard - excipient ingredients: colloidal anhydrous silica; calcium hydrogen phosphate dihydrate; ascorbyl palmitate; microcrystalline cellulose; betadex; hypromellose; potable water - maintain/support general health and wellbeing ; anti-inflammatory/relieve inflammation ; analgesic/anodyne/relieve pain ; decrease/reduce/relieve mild nerve pain/neuralgia

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

designs for health pty ltd - withania somnifera, quantity: 33 mg (equivalent: withania somnifera, qty 188.1 mg); withania somnifera, quantity: 150 mg (equivalent: withania somnifera, qty 5.7 g); withania somnifera, quantity: 150 mg (equivalent: withania somnifera, qty 1.5 g) - capsule, hard - excipient ingredients: calcium hydrogen phosphate dihydrate; colloidal anhydrous silica; magnesium stearate; hypromellose; lecithin; gamma-cyclodextrin; purified water; maltodextrin; betadex; silicon dioxide; modified food starch - traditionally used in ayurvedic medicine to aids/assists with recovery from illness/convalescence ; traditionally used in ayurvedic medicine to relieve feelings of general malaise/general debility ; traditionally used in ayurvedic medicine to rejuvenating tonic ; traditionally used in ayurvedic medicine to adaptogen/help body adapt to stress ; traditionally used in ayurvedic medicine to nerve tonic

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

bio concepts pty ltd - palmidrol, quantity: 600 mg; piper nigrum, quantity: 100 mg (equivalent: piper nigrum, qty 5 g) - capsule, hard - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate dihydrate; colloidal anhydrous silica; ascorbyl palmitate; betadex; hypromellose; potable water - maintain/support general health and wellbeing ; anti-inflammatory/relieve inflammation ; analgesic/anodyne/relieve pain ; decrease/reduce/relieve mild nerve pain/neuralgia

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - drospirenone,ethinylestradiol -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - ethinylestradiol, quantity: 20 microgram; drospirenone, quantity: 3 mg - tablet, uncoated - excipient ingredients: magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; purified talc; microcrystalline cellulose - yaz is indicated for use as: - an oral contraceptive. - treatment of moderate acne vulgaris in women who seek oral contraception - treatment of symptoms of premenstrual dysphoric disorder (pmdd) in women who have chosen oral contraceptives as their method of birth control. the efficacy of yaz for pmdd was not assessed beyond 3 cycles. yaz has not been evaluated for treatment of pms (premenstrual syndrome), see clinical trials.

Izrael - angol - Ministry of Health

bayer israel ltd - drospirenone; ethinylestradiol as betadex clathrate; levomefolate calcium; levomefolate calcium - film coated tablets - levomefolate calcium 0.451 mg; ethinylestradiol as betadex clathrate 0.03 mg; drospirenone 3 mg; levomefolate calcium 0.451 mg - estradiol, combinations - oral contraceptive. in women who choose to use an oral contraceptive as their method of contraception, to raise folate levels for the purpose of reducing the risk of a neural tube defect in a pregnancy conceived while taking the product or shortly after discontinuing the product.

Egyesült Államok - angol - NLM (National Library of Medicine)

siga technologies, inc. - tecovirimat (unii: f925rr824r) (tecovirimat - unii:f925rr824r) - tpoxx® is indicated for the treatment of human smallpox disease caused by variola virus in adults and pediatric patients weighing at least 3 kg. the effectiveness of tpoxx for treatment of smallpox disease has not been determined in humans because adequate and well-controlled field trials have not been feasible, and inducing smallpox disease in humans to study the drug’s efficacy is not ethical [see clinical studies (14)] . tpoxx efficacy may be reduced in immunocompromised patients based on studies demonstrating reduced efficacy in immunocompromised animal models. tpoxx capsules: none. tpoxx injection: the excipient hydroxypropyl-β-cyclodextrin is eliminated through glomerular filtration. therefore, tpoxx injection is contraindicated in patients with severe renal impairment (defined as creatinine clearance below 30 ml/min) [see warnings and precautions (5.2) and use in specific populations (8.6)] . risk summary there are no available data on the use of tecovirimat in pregnant individuals to evaluate for a